TABLE 3.
The scores of MINORS.
| No | Study | Clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to the aim of the study | Unbiased assessment of the study endpoint | Follow-up period appropriate to the aim of the study | Loss to follow up less than 5% | Prospective calculation of the study size | MINORS score |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lin Y | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 | 12 |
| 2 | Jennifer N. Brudno | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 16 |
| 3 | Hao S | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 | 12 |
| 4 | Alsina M | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 13 |
| 5 | Wan-Hong Zhao | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
| 6 | Sham Mailankody | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 6 |
| 7 | Kumar SK | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 12 |
| 8 | Sham Mailankody | 2 | 0 | 2 | 2 | 2 | 0 | 2 | 0 | 10 |
| 9 | Di Wang | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 12 |
| 10 | Shwetha H. Manjunath | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 12 |
| 11 | Damian J. Green | 2 | 0 | 2 | 2 | 2 | 0 | 2 | 0 | 10 |
| 12 | Jesus G Berdeja MD | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 0 | 13 |
| 13 | Nikhil C. Munshi | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
| 14 | XiaoYuan, Zhang | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 16 |
| 15 | Juan Du | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 15 |
| 16 | Xiaoyan Qu | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
| 17 | Chen W | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
| 18 | Costello CL | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 12 |
| 19 | Frigault MJ | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
| 20 | Hu Y | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 14 |
| 21 | Chunrui Li | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 16 |